References
- Ellulu MS, Patimah I, Khaza’ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863. doi:https://doi.org/10.5114/aoms.2016.58928.
- Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17. doi:https://doi.org/10.1007/978-3-319-48382-5_1.
- Bandini M, Gandaglia G, Briganti A. Obesity and prostate cancer. Curr Opin Urol. 2017;27(5):415–421. doi:https://doi.org/10.1097/MOU.0000000000000424.
- Lavalette C, Trétarre B, Rebillard X, et al. Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget. 2018;9(77):34485–34494. doi:https://doi.org/10.18632/oncotarget.26128.
- Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, et al. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–397. doi:https://doi.org/10.3322/caac.21405.
- Dougan MM, Hankinson SE, Vivo ID, et al. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer. 2015;137(3):625–637. doi:https://doi.org/10.1002/ijc.29427.
- Chen Y, Wang X, Wang J, et al. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48(14):2137–2145. doi:https://doi.org/10.1016/j.ejca.2012.02.063.
- Lee K, Kruper L, Dieli-Conwright CM, et al. The impact of obesity on breast cancer diagnosis and treatment. Curr Oncol Rep. 2019;21(5):41–41. doi:https://doi.org/10.1007/s11912-019-0787-1.
- Ross KH, Gogineni K, Subhedar PD, et al. Obesity and cancer treatment efficacy: existing challenges and opportunities. Cancer. 2019;125(10):1588–1592. doi:https://doi.org/10.1002/cncr.31976.
- Di Cosimo S, Porcu L, Agbor-Tarh D, et al. Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial. Breast Cancer Res. 2020;22(1):115. doi:https://doi.org/10.1186/s13058-020-01356-w.
- Ghilotti F, Bellocco R, Ye W, et al. Obesity and risk of infections: results from men and women in the Swedish National March Cohort. Int J Epidemiol. 2019;48(6):1783–1794. doi:https://doi.org/10.1093/ije/dyz129.
- Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438–446. doi:https://doi.org/10.1016/S1473-3099(06)70523-0.
- Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37(3):333–340. doi:https://doi.org/10.1038/ijo.2012.62.
- Kaspersen KA, Pedersen OB, Petersen MS, et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology. 2015;26(4):580–589. doi:https://doi.org/10.1097/EDE.0000000000000301.
- Bochicchio GV, Joshi M, Bochicchio K, et al. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg. 2006;203(4):533–538. doi:https://doi.org/10.1016/j.jamcollsurg.2006.07.001.
- Gremese E, Tolusso B, Gigante MR, et al. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol. 2014;5:576. doi:https://doi.org/10.3389/fimmu.2014.00576.
- Tsigalou C, Vallianou N, Dalamaga M. Autoantibody production in obesity: is there evidence for a link between obesity and autoimmunity?Curr Obes Rep. 2020;9(3):245–254. doi:https://doi.org/10.1007/s13679-020-00397-8.
- Ohno T, Aune D, Heath AK. Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Sci Rep. 2020;10(1):16006. doi:https://doi.org/10.1038/s41598-020-71676-6.
- Jensen P, Skov L. Psoriasis and obesity. Dermatology. 2016;232(6):633–639. doi:https://doi.org/10.1159/000455840.
- Queiro R, Lorenzo A, Tejón P, et al. Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore ). 2019;98(28):e16400. doi:https://doi.org/10.1097/MD.0000000000016400.
- Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. doi:https://doi.org/10.1038/nri2921.
- Scarpellini E, Tack J. Obesity and metabolic syndrome: an inflammatory condition. Dig Dis. 2012;30(2):148–153. doi:https://doi.org/10.1159/000336664.
- Huang-Doran I, Zhang CY, Vidal-Puig A. Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab. 2017;28(1):3–18. doi:https://doi.org/10.1016/j.tem.2016.10.003.
- van der Pol E, Böing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676–705. doi:https://doi.org/10.1124/pr.112.005983.
- Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195–208. doi:https://doi.org/10.1038/nri3622.
- Deatherage BL, Cookson BT. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun. 2012;80(6):1948–1957. doi:https://doi.org/10.1128/IAI.06014-11.
- Lee EY, Choi DY, Kim DK, et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics. 2009;9(24):5425–5436. doi:https://doi.org/10.1002/pmic.200900338.
- Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition. Cell. 2019;177(2):428–445.e18. doi:https://doi.org/10.1016/j.cell.2019.02.029.
- Wang Y, Zhao M, Liu S, et al. Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases. Cell Death Dis. 2020;11(10):924. doi:https://doi.org/10.1038/s41419-020-03127-z.
- Di Vizio D, Kim J, Hager MH, et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009;69(13):5601–5609. doi:https://doi.org/10.1158/0008-5472.CAN-08-3860.
- Morello M, Minciacchi V, de Candia P, et al. Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle. 2013;12(22):3526–3536. doi:https://doi.org/10.4161/cc.26539.
- Zhang H, Freitas D, Kim HS, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20(3):332–343. doi:https://doi.org/10.1038/s41556-018-0040-4.
- Zhang Q, Higginbotham JN, Jeppesen DK, et al. Transfer of functional cargo in exomeres. Cell Rep. 2019;27(3):940–954.e6. doi:https://doi.org/10.1016/j.celrep.2019.01.009.
- Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579. doi:https://doi.org/10.1038/nri855.
- Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013;27(1):31–39. doi:https://doi.org/10.1016/j.blre.2012.12.002.
- Théry C, Boussac M, Véron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001;166(12):7309–7318. doi:https://doi.org/10.4049/jimmunol.166.12.7309.
- Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161–1172. doi:https://doi.org/10.1084/jem.183.3.1161.
- Clayton A, Court J, Navabi H, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001;247(1–2):163–174. doi:https://doi.org/10.1016/S0022-1759(00)00321-5.
- Blanchard N, Lankar D, Faure F, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol. 2002;168(7):3235–3241. doi:https://doi.org/10.4049/jimmunol.168.7.3235.
- Théry C, Regnault A, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147(3):599–610. doi:https://doi.org/10.1083/jcb.147.3.599.
- Dang VD, Jella KK, Ragheb RRT, et al. Lipidomic and proteomic analysis of exosomes from mouse cortical collecting duct cells. FASEB J. 2017;31(12):5399–5408. doi:https://doi.org/10.1096/fj.201700417R.
- Ridder K, Keller S, Dams M, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol. 2014;12(6):e1001874. doi:https://doi.org/10.1371/journal.pbio.1001874.
- György B, Szabó TG, Pásztói M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667–2688. doi:https://doi.org/10.1007/s00018-011-0689-3.
- Salzer U, Hinterdorfer P, Hunger U, et al. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood. 2002;99(7):2569–2577. doi:https://doi.org/10.1182/blood.v99.7.2569.
- Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109(4):175–180. doi:https://doi.org/10.1016/s0049-3848(03)00064-1.
- Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol. 2008;20(1):4–11. doi:https://doi.org/10.1016/j.ceb.2007.12.002.
- Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol. 2009;10(9):597–608. doi:https://doi.org/10.1038/nrm2755.
- Goldenring JR. Recycling endosomes. Curr Opin Cell Biol. 2015;35:117–122. doi:https://doi.org/10.1016/j.ceb.2015.04.018.
- Karim MA, Samyn DR, Mattie S, et al. Distinct features of multivesicular body-lysosome fusion revealed by a new cell-free content-mixing assay. Traffic. 2018;19(2):138–149. doi:https://doi.org/10.1111/tra.12543.
- Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014;5:442. doi:https://doi.org/10.3389/fimmu.2014.00442.
- Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36(3):301–312. doi:https://doi.org/10.1007/s10571-016-0366-z.
- Hurley JH. ESCRTs are everywhere. EMBO J. 2015;34(19):2398–2407. doi:https://doi.org/10.15252/embj.201592484.
- Christ L, Raiborg C, Wenzel EM, et al. Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery. Trends Biochem Sci. 2017;42(1):42–56. doi:https://doi.org/10.1016/j.tibs.2016.08.016.
- Olmos Y, Carlton JG. The ESCRT machinery: new roles at new holes. Curr Opin Cell Biol. 2016;38:1–11. doi:https://doi.org/10.1016/j.ceb.2015.12.001.
- Gatta AT, Carlton JG. The ESCRT-machinery: closing holes and expanding roles. Curr Opin Cell Biol. 2019;59:121–132. doi:https://doi.org/10.1016/j.ceb.2019.04.005.
- Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30. doi:https://doi.org/10.1038/ncb2000.
- Campsteijn C, Vietri M, Stenmark H. Novel ESCRT functions in cell biology: spiraling out of control?Curr Opin Cell Biol. 2016;41:1–8. doi:https://doi.org/10.1016/j.ceb.2016.03.008.
- Iraci N, Leonardi T, Gessler F, et al. Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci. 2016;17(2):171–171. doi:https://doi.org/10.3390/ijms17020171.
- Teng F, Fussenegger M. Shedding light on extracellular vesicle biogenesis and bioengineering. Adv Sci (Weinh). 2020;8(1):2003505. doi:https://doi.org/10.1002/advs.202003505.
- Clancy JW, Schmidtmann M, D’Souza-Schorey C. The ins and outs of microvesicles. FASEB Bioadv. 2021;3:399–407. doi:https://doi.org/10.1096/fba.2020-00127.
- Colletti M, Ceglie D, Di Giannatale A, et al. Autophagy and exosomes relationship in cancer: friends or foes?Front Cell Dev Biol. 2020;8:614178. doi:https://doi.org/10.3389/fcell.2020.614178.
- Purvinsh L, Gorshkov A, Brodskaia A, et al. Extracellular vesicles in viral pathogenesis: a case of Dr. Jekyll and Mr. Hyde. Life (Basel). 2021;11(1). doi:https://doi.org/10.3390/life11010045.
- Batista IA, Quintas ST, Melo SA. The interplay of exosomes and NK cells in cancer biology. Cancers (Basel). 2021;13(3). doi:https://doi.org/10.3390/cancers13030473.
- Du T, Yang C-L, Ge M-R, et al. M1 macrophage derived exosomes aggravate experimental autoimmune neuritis via modulating Th1 response. Front Immunol. 2020;11:1603–1603. doi:https://doi.org/10.3389/fimmu.2020.01603.
- Coakley G, Maizels RM, Buck AH. Exosomes and other extracellular vesicles: the new communicators in parasite infections. Trends Parasitol. 2015;31(10):477–489. doi:https://doi.org/10.1016/j.pt.2015.06.009.
- Hutcheson JD, Aikawa E. Extracellular vesicles in cardiovascular homeostasis and disease. Curr Opin Cardiol. 2018;33(3):290–297. doi:https://doi.org/10.1097/HCO.0000000000000510.
- Stahl PD, Raposo G. Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology (Bethesda). 2019;34(3):169–177. doi:https://doi.org/10.1152/physiol.00045.2018.
- Zhou X, Xie F, Wang L, et al. The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol. 2020;17(4):323–334. doi:https://doi.org/10.1038/s41423-020-0391-1.
- Daryabor G, Kabelitz D, Kalantar K. An update on immune dysregulation in obesity-related insulin resistance. Scand J Immunol. 2019;89(4):e12747. doi:https://doi.org/10.1111/sji.12747.
- Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191–200. doi:https://doi.org/10.5114/aoms.2013.33181.
- Cawthorn WP, Scheller EL, Learman BS, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014;20(2):368–375. doi:https://doi.org/10.1016/j.cmet.2014.06.003.
- Trzeciak-Ryczek A, Tokarz-Deptuła B, Niedźwiedzka-Rystwej P, et al. Adipose tissue–component of the immune system. Centr Eur J Immunol. 2011;36(2):95–99.
- Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, et al. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J). 2007;83(5):S192–S203. doi:https://doi.org/10.1590/S0021-75572007000700011.
- Carmean CM, Cohen RN, Brady MJ. Systemic regulation of adipose metabolism. Biochim Biophys Acta. 2014;1842(3):424–430. doi:https://doi.org/10.1016/j.bbadis.2013.06.004.
- Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327–332. doi:https://doi.org/10.1016/s1043-2760(00)00301-5.
- Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184. doi:https://doi.org/10.1172/JCI29881.
- Glastonbury CA, Couto Alves A, El-Sayed Moustafa JS, et al. Cell-type heterogeneity in adipose tissue is associated with complex traits and reveals disease-relevant cell-specific eQTLs. Am J Hum Genet. 2019;104(6):1013–1024. doi:https://doi.org/10.1016/j.ajhg.2019.03.025.
- Saely CH, Geiger K, Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology. 2012;58(1):15–23. doi:https://doi.org/10.1159/000321319.
- Durcin M, Fleury A, Taillebois E, et al. Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles. J Extracell Vesicles. 2017;6(1):1305677. doi:https://doi.org/10.1080/20013078.2017.1305677.
- Kranendonk ME, Visseren FL, van Balkom BW, et al. Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages. Obesity (Silver Spring). 2014;22(5):1296–1308. doi:https://doi.org/10.1002/oby.20679.
- Kranendonk ME, Visseren FL, van Herwaarden JA, et al. Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells. Obesity (Silver Spring). 2014;22(10):2216–2223. doi:https://doi.org/10.1002/oby.20847.
- Connolly KD, Guschina IA, Yeung V, et al. Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipogenesis. J Extracell Vesicles. 2015;4(1):29159. doi:https://doi.org/10.3402/jev.v4.29159.
- Kumar A, Sundaram K, Mu J, et al. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance. Nat Commun. 2021;12(1):213. doi:https://doi.org/10.1038/s41467-020-20500-w.
- Lin X, Taguchi A, Park S, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest. 2004;114(7):908–916. doi:https://doi.org/10.1172/JCI22217.
- Xu CX, Wang C, Zhang ZM, et al. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure. Int J Obes (Lond). 2015;39(8):1300–1309. doi:https://doi.org/10.1038/ijo.2015.63.
- Esser J, Gehrmann U, D’Alexandri FL, et al. Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration. J Allergy Clin Immunol. 2010;126(5):1032–1040. doi:https://doi.org/10.1016/j.jaci.2010.06.039.
- MacKenzie A, Wilson HL, Kiss-Toth E, et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity. 2001;15(5):825–835. doi:https://doi.org/10.1016/s1074-7613(01)00229-1.
- Pizzirani C, Ferrari D, Chiozzi P, et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood. 2007;109(9):3856–3864. doi:https://doi.org/10.1182/blood-2005-06-031377.
- Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol. 2007;179(3):1913–1925. doi:https://doi.org/10.4049/jimmunol.179.3.1913.
- Amosse J, Durcin M, Malloci M, et al. Phenotyping of circulating extracellular vesicles (EVs) in obesity identifies large EVs as functional conveyors of macrophage migration inhibitory factor. Mol Metab. 2018;18:134–142. doi:https://doi.org/10.1016/j.molmet.2018.10.001.
- Richardson ET, Shukla S, Nagy N, et al. ERK signaling is essential for macrophage development. PLoS One. 2015;10(10):e0140064. doi:https://doi.org/10.1371/journal.pone.0140064.
- Kumar V. Targeting macrophage immunometabolism: Dawn in the darkness of sepsis. Int Immunopharmacol. 2018;58:173–185. doi:https://doi.org/10.1016/j.intimp.2018.03.005.
- Través PG, de Atauri P, Marín S, et al. Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach. J Immunol. 2012;188(3):1402–1410. doi:https://doi.org/10.4049/jimmunol.1101781.
- Chang PF, Reyna SM. 1732-P: ERK1 and ERK2 are required for lipopolysaccharide-induced production of cytokines and chemokines by macrophages. Diabetes. 2019;68(Supplement 1):1732-P. doi:https://doi.org/10.2337/db19-1732-P.
- Chang PF, Acevedo D, Reyna SM. Role of ERK in IRF3-mediated immune responses. Diabetes. 2018;67(Supplement 1):244-LB. doi:https://doi.org/10.2337/db18-244-LB.
- Schindler L, Zwissler L, Krammer C, et al. Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells. J Leukocyte Biol. 2021. doi:https://doi.org/10.1002/JLB.3A0420-242RRR.
- Bach JP, Rinn B, Meyer B, et al. Role of MIF in Inflammation and Tumorigenesis. Oncology. 2008;75(3–4):127–133. doi:https://doi.org/10.1159/000155223.
- Conroy H, Mawhinney L, Donnelly SC. Inflammation and cancer: macrophage migration inhibitory factor (MIF)-the potential missing link. QJM. 2010;103(11):831–836. doi:https://doi.org/10.1093/qjmed/hcq148.
- Kasama T, Ohtsuka K, Sato M, et al. Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases. Arthritis. 2010;2010:106202. doi:https://doi.org/10.1155/2010/106202.
- Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012;18(9):1407–1412. doi:https://doi.org/10.1038/nm.2885.
- Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800. doi:https://doi.org/10.1038/nri1200.
- Lyu Y, Su X, Deng J, et al. Defective differentiation of adipose precursor cells from lipodystrophic mice lacking perilipin 1. PLoS One. 2015;10(2):e0117536. doi:https://doi.org/10.1371/journal.pone.0117536.
- Li S, Raza SHA, Zhao C, et al. Overexpression of PLIN1 promotes lipid metabolism in bovine adipocytes. Animals (Basel). 2020;10(11). doi:https://doi.org/10.3390/ani10111944.
- Eguchi A, Lazic M, Armando AM, et al. Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress. J Mol Med (Berl). 2016;94(11):1241–1253. doi:https://doi.org/10.1007/s00109-016-1446-8.
- Kobayashi Y, Eguchi A, Tempaku M, et al. Circulating extracellular vesicles are associated with lipid and insulin metabolism. Am J Physiol Endocrinol Metab. 2018;315(4):E574–E582. doi:https://doi.org/10.1152/ajpendo.00160.2018.
- Sohn JH, Lee YK, Han JS, et al. Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation. J Biol Chem. 2018; 293(36):13974–13988. doi:https://doi.org/10.1074/jbc.RA118.003541.
- Corvillo F, Aparicio V, López-Lera A, et al. Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy. Front Immunol. 2018;9:2142–2142. doi:https://doi.org/10.3389/fimmu.2018.02142.
- Monson EA, Crosse KM, Das M, et al. Lipid droplet density alters the early innate immune response to viral infection. PLoS One. 2018;13(1):e0190597. doi:https://doi.org/10.1371/journal.pone.0190597.
- Zechner R, Madeo F, Kratky D. Cytosolic lipolysis and lipophagy: two sides of the same coin. Nat Rev Mol Cell Biol. 2017;18(11):671–684. doi:https://doi.org/10.1038/nrm.2017.76.
- Ju L, Han J, Zhang X, et al. Obesity-associated inflammation triggers an autophagy-lysosomal response in adipocytes and causes degradation of perilipin 1. Cell Death Dis. 2019;10(2):121. doi:https://doi.org/10.1038/s41419-019-1393-8.
- Drizyte-Miller K, Schott MB, McNiven MA. Lipid droplet contacts with autophagosomes. Contact (Thousand Oaks). 2020;3:1–13. doi:https://doi.org/10.1177/2515256420910892.
- Zhang S, Liu G, Xu C, et al. Perilipin 1 mediates lipid metabolism homeostasis and inhibits inflammatory cytokine synthesis in bovine adipocytes. Front Immunol. 2018;9:467–467. doi:https://doi.org/10.3389/fimmu.2018.00467.
- Saitoh T, Satoh T, Yamamoto N, et al. Antiviral protein viperin promotes toll-like receptor 7- and toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity. 2011;34(3):352–363. doi:https://doi.org/10.1016/j.immuni.2011.03.010.
- Ballak DB, van Asseldonk EJ, van Diepen JA, et al. TLR-3 is present in human adipocytes, but its signalling is not required for obesity-induced inflammation in adipose tissue in vivo. PLoS One. 2015;10(4):e0123152. doi:https://doi.org/10.1371/journal.pone.0123152.
- Sindhu S, Wilson A, Akhtar N, et al. Increased adipose tissue expression of toll-like receptor (TLR)-7 in obese individuals: significance in metabolic disease. J Glycomics Lipidomics. 2015;5(4):1–6.
- Kim SJ, Choi Y, Choi YH, et al. Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem. 2012;23(2):113–122. doi:https://doi.org/10.1016/j.jnutbio.2010.10.012.
- Latorre J, Moreno-Navarrete JM, Sabater M, et al. Decreased TLR3 in hyperplastic adipose tissue, blood and inflamed adipocytes is related to metabolic inflammation. Cell Physiol Biochem. 2018;51(3):1051–1068. doi:https://doi.org/10.1159/000495487.
- Kanda T, Yokosuka O, Imazeki F, et al. Body mass index in Japanese patients with autoimmune liver disease: overweight patients with primary biliary cirrhosis tend to be asymptomatic. Hepatogastroenterology. 2007;54(78):1758–1760.
- Roggenbuck D, Mytilinaiou MG, Lapin SV, et al. Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. Auto Immun Highlights. 2012;3(3):119–125. doi:https://doi.org/10.1007/s13317-012-0041-4.
- Villalta D, Mytilinaiou MG, Elsner M, et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases. Clin Chim Acta. 2015;450:1–5. doi:https://doi.org/10.1016/j.cca.2015.07.021.
- Rigopoulou EI, Roggenbuck D, Smyk DS, et al. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012;12(2):260–269. doi:https://doi.org/10.1016/j.autrev.2012.04.005.
- Löhr H, Treichel U, Poralla T, et al. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology. 1990;12(6):1314–1320. doi:https://doi.org/10.1002/hep.1840120611.
- Harris RL, van den Berg CW, Bowen DJ. ASGR1 and ASGR2, the genes that encode the asialoglycoprotein receptor (ashwell receptor), are expressed in peripheral blood monocytes and show interindividual differences in transcript profile. Mol Biol Int. 2012;2012:283974. doi:https://doi.org/10.1155/2012/283974.
- Mi Y, Coonce M, Fiete D, et al. Functional consequences of mannose and asialoglycoprotein receptor ablation. J Biol Chem. 2016;291(36):18700–18717. doi:https://doi.org/10.1074/jbc.M116.738948.
- Tousoulis D, Davies G, Stefanadis C, et al. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart. 2003;89(9):993–997. doi:https://doi.org/10.1136/heart.89.9.993.
- Kaye SM, Pietiläinen KH, Kotronen A, et al. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity. 2012;20(1):88–94. doi:https://doi.org/10.1038/oby.2011.287.
- Saunier B, Triyatni M, Ulianich L, et al. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol. 2003;77(1):546–559. doi:https://doi.org/10.1128/jvi.77.1.546-559.2003.
- Ying W, Riopel M, Bandyopadhyay G, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell. 2017;171(2):372–384.e12. doi:https://doi.org/10.1016/j.cell.2017.08.035.
- Gao H, Luo Z, Jin Z, et al. Adipose tissue macrophages orchestrate β cell adaptation in obesity through secreting miRNA-containing extracellular vesicles. bioRxiv. 2020. doi:https://doi.org/10.1101/2020.06.12.148809.
- Chen Y, Siegel F, Kipschull S, et al. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun. 2013;4:1769. doi:https://doi.org/10.1038/ncomms2742.
- Ortega FJ, Moreno M, Mercader JM, et al. Inflammation triggers specific microRNA profiles in human adipocytes and macrophages and in their supernatants. Clin Epigenetics. 2015;7(1):49. doi:https://doi.org/10.1186/s13148-015-0083-3.
- De Silva N, Samblas M, Martínez JA, et al. Effects of exosomes from LPS-activated macrophages on adipocyte gene expression, differentiation, and insulin-dependent glucose uptake. J Physiol Biochem. 2018;74(4):559–568. doi:https://doi.org/10.1007/s13105-018-0622-4.
- Goulielmaki E, Ioannidou A, Tsekrekou M, et al. Tissue-infiltrating macrophages mediate an exosome-based metabolic reprogramming upon DNA damage. Nat Commun. 2020;11(1):42. doi:https://doi.org/10.1038/s41467-019-13894-9.
- Togliatto G, Dentelli P, Gili M, et al. Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications. Int J Obes (Lond). 2016;40(1):102–111. doi:https://doi.org/10.1038/ijo.2015.123.
- Stepanian A, Bourguignat L, Hennou S, et al. Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring). 2013;21(11):2236–2243. doi:https://doi.org/10.1002/oby.20365.
- Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13(3):269–288. doi:https://doi.org/10.1111/j.1365-2141.1967.tb08741.x.
- Webber AJ, Johnson SA. Platelet participation in blood coagulation aspects of hemostasis. Am J Pathol. 1970;60(1):19–42.
- Puhm F, Boilard E, Machlus KR. Platelet extracellular vesicles: beyond the blood. Arterioscler Thromb Vasc Biol. 2021;41(1):87–96. doi:https://doi.org/10.1161/ATVBAHA.120.314644.
- Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150–161. doi:https://doi.org/10.2174/157340310791658730.
- Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154(3):485–490. doi:https://doi.org/10.1083/jcb.200105058.
- Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010;327(5965):580–583. doi:https://doi.org/10.1126/science.1181928.
- Boilard E. Thematic review series: exosomes and microvesicles: lipids as key components of their biogenesis and functions extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA. J Lipid Res. 2018;59(11):2037–2046. doi:https://doi.org/10.1194/jlr.R084640.
- Cloutier N, Tan S, Boudreau LH, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med. 2013;5(2):235–249. doi:https://doi.org/10.1002/emmm.201201846.
- Maugeri N, Capobianco A, Rovere-Querini P, et al. Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis. Sci Transl Med. 2018;10(451):eaao3089. doi:https://doi.org/10.1126/scitranslmed.aao3089.
- Duchez A-C, Boudreau LH, Naika GS, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A-IIA. Proc Natl Acad Sci USA. 2015;112(27):E3564–E3573. doi:https://doi.org/10.1073/pnas.1507905112.
- Tang K, Liu J, Yang Z, et al. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. Biochem Biophys Res Commun. 2010;400(3):432–436. doi:https://doi.org/10.1016/j.bbrc.2010.08.095.
- Braig D, Nero TL, Koch H-G, et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun. 2017;8(1):14188. doi:https://doi.org/10.1038/ncomms14188.
- Nakashima K, Hagiwara T, Yamada M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem. 2002;277(51):49562–49568. doi:https://doi.org/10.1074/jbc.M208795200.
- Vossenaar ER, Zendman AJW, van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25(11):1106–1118. doi:https://doi.org/10.1002/bies.10357.
- Jones JE, Causey CP, Knuckley B, et al. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel. 2009;12(5):616–627.
- Anzilotti C, Pratesi F, Tommasi C, et al. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev. 2010;9(3):158–160. doi:https://doi.org/10.1016/j.autrev.2009.06.002.
- Sadallah S, Eken C, Martin PJ, Schifferli JA. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol. 2011;186(11):6543–6552. doi:https://doi.org/10.4049/jimmunol.1002788.
- Lopez E, Srivastava AK, Burchfield J, et al. Platelet-derived- extracellular vesicles promote hemostasis and prevent the development of hemorrhagic shock. Sci Rep. 2019;9(1):17676. doi:https://doi.org/10.1038/s41598-019-53724-y.
- Clayton A, Harris CL, Court J, et al. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003;33(2):522–531. doi:https://doi.org/10.1002/immu.200310028.
- French SL, Butov KR, Allaeys I, et al. Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. Blood Adv. 2020;4(13):3011–3023. doi:https://doi.org/10.1182/bloodadvances.2020001758.
- Giannella A, Radu CM, Franco L, et al. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Cardiovasc Diabetol. 2017;16(1):118. doi:https://doi.org/10.1186/s12933-017-0600-0.
- Jansen F, Wang H, Przybilla D, et al. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol. 2016;15:49. doi:https://doi.org/10.1186/s12933-016-0367-8.
- Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013;128(18):2026–2038. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.001720.
- Sabzevari Rad R, Shirvani H, Mahmoodzadeh Hosseini H, et al. Micro RNA-126 promoting angiogenesis in diabetic heart by VEGF/Spred-1/Raf-1 pathway: effects of high-intensity interval training. J Diabetes Metab Disord. 2020;19(2):1089–1096. doi:https://doi.org/10.1007/s40200-020-00610-4.
- Pardo F, Villalobos-Labra R, Sobrevia B, et al. Extracellular vesicles in obesity and diabetes mellitus. Mol Aspects Med. 2018;60:81–91. doi:https://doi.org/10.1016/j.mam.2017.11.010.
- Akbar N, Azzimato V, Choudhury RP, et al. Extracellular vesicles in metabolic disease. Diabetologia. 2019;62(12):2179–2187. doi:https://doi.org/10.1007/s00125-019-05014-5.